{"relationship_key":"MeSH:D011471:increases_risk:prov:837d4174be754e9b930c5ba9437af68e","document_id":"PMC12756687_window_1","section":null,"start_offset":0,"end_offset":0,"text_span":"epidemiologic risk factors may include prostate cancer and associated endocrine therapy, gynecomastia","confidence":0.8,"supports":true}
{"relationship_key":"MeSH:D011471:increases_risk:prov:837d4174be754e9b930c5ba9437af68e","document_id":"PMC12756687_window_1","section":null,"start_offset":0,"end_offset":0,"text_span":"epidemiologic risk factors may include prostate cancer and associated endocrine therapy, gynecomastia","confidence":0.8,"supports":true}
{"relationship_key":"DBPedia:Metastasis:associated_with:MeSH:D001943","document_id":"PMC12756687_window_1","section":null,"start_offset":0,"end_offset":0,"text_span":"Here we report an unusual case of cytological pleural metastasis from male breast cancer.","confidence":0.9,"supports":true}
{"relationship_key":"DBPedia:Metastasis:associated_with:MeSH:D001943","document_id":"PMC12756687_window_1","section":null,"start_offset":0,"end_offset":0,"text_span":"Here we report an unusual case of cytological pleural metastasis from male breast cancer.","confidence":0.9,"supports":true}
{"relationship_key":"UniProt:M5AWW0:associated_with:prov:67fa0a2098f84f71bb4f50e2d3b9500e","document_id":"PMC12756687_window_4","section":null,"start_offset":0,"end_offset":0,"text_span":"The tumor cells are positive for BerEp4 (B), CAM5.2 (E)","confidence":0.8,"supports":true}
{"relationship_key":"UniProt:M5AWW0:associated_with:prov:67fa0a2098f84f71bb4f50e2d3b9500e","document_id":"PMC12756687_window_4","section":null,"start_offset":0,"end_offset":0,"text_span":"The tumor cells are positive for BerEp4 (B), CAM5.2 (E)","confidence":0.8,"supports":true}
{"relationship_key":"prov:5c3008e0dd1244e383d15289515ad8d5:indicates:prov:67fa0a2098f84f71bb4f50e2d3b9500e","document_id":"PMC12756687_window_4","section":null,"start_offset":0,"end_offset":0,"text_span":"IHC revealed a positivity of the tumor cells for BerEp4","confidence":0.9,"supports":true}
{"relationship_key":"prov:5c3008e0dd1244e383d15289515ad8d5:indicates:prov:67fa0a2098f84f71bb4f50e2d3b9500e","document_id":"PMC12756687_window_4","section":null,"start_offset":0,"end_offset":0,"text_span":"IHC revealed a positivity of the tumor cells for BerEp4","confidence":0.9,"supports":true}
{"relationship_key":"DBPedia:PARP_inhibitor:treats:prov:685499061f8c420890b6a36d7399255d","document_id":"PMC12756687_window_6","section":null,"start_offset":0,"end_offset":0,"text_span":"the role and understanding of germline mutations with increased prevalence in MBC, such as BRCA2, may help with the identification of novel treatment options such as PARP inhibitors.","confidence":0.8,"supports":true}
{"relationship_key":"DBPedia:PARP_inhibitor:treats:prov:685499061f8c420890b6a36d7399255d","document_id":"PMC12756687_window_6","section":null,"start_offset":0,"end_offset":0,"text_span":"the role and understanding of germline mutations with increased prevalence in MBC, such as BRCA2, may help with the identification of novel treatment options such as PARP inhibitors.","confidence":0.8,"supports":true}
{"relationship_key":"UniProt:Q1RPA4:indicates:prov:685499061f8c420890b6a36d7399255d","document_id":"PMC12756687_window_6","section":null,"start_offset":0,"end_offset":0,"text_span":"Specifically, estrogen receptors (ER) are expressed in more than 90% and progesterone receptors (PR) are in more than 80% of male breast cases","confidence":0.9,"supports":true}
{"relationship_key":"UniProt:Q1RPA4:indicates:prov:685499061f8c420890b6a36d7399255d","document_id":"PMC12756687_window_6","section":null,"start_offset":0,"end_offset":0,"text_span":"Specifically, estrogen receptors (ER) are expressed in more than 90% and progesterone receptors (PR) are in more than 80% of male breast cases","confidence":0.9,"supports":true}
{"relationship_key":"UniProt:Q1RPA2:indicates:prov:685499061f8c420890b6a36d7399255d","document_id":"PMC12756687_window_6","section":null,"start_offset":0,"end_offset":0,"text_span":"Specifically, estrogen receptors (ER) are expressed in more than 90% and progesterone receptors (PR) are in more than 80% of male breast cases","confidence":0.9,"supports":true}
{"relationship_key":"UniProt:Q1RPA2:indicates:prov:685499061f8c420890b6a36d7399255d","document_id":"PMC12756687_window_6","section":null,"start_offset":0,"end_offset":0,"text_span":"Specifically, estrogen receptors (ER) are expressed in more than 90% and progesterone receptors (PR) are in more than 80% of male breast cases","confidence":0.9,"supports":true}
{"relationship_key":"UniProt:Q1RPA4:associated_with:MeSH:D010996","document_id":"PMC12756687_window_6","section":null,"start_offset":0,"end_offset":0,"text_span":"Therefore, the presence of both ER and PR plays a crucial role in determining if the primary disease behind the metastatic pleural effusions is breast cancer.","confidence":0.8,"supports":true}
{"relationship_key":"UniProt:Q1RPA4:associated_with:MeSH:D010996","document_id":"PMC12756687_window_6","section":null,"start_offset":0,"end_offset":0,"text_span":"Therefore, the presence of both ER and PR plays a crucial role in determining if the primary disease behind the metastatic pleural effusions is breast cancer.","confidence":0.8,"supports":true}
{"relationship_key":"UniProt:Q1RPA2:associated_with:MeSH:D010996","document_id":"PMC12756687_window_6","section":null,"start_offset":0,"end_offset":0,"text_span":"Therefore, the presence of both ER and PR plays a crucial role in determining if the primary disease behind the metastatic pleural effusions is breast cancer.","confidence":0.8,"supports":true}
{"relationship_key":"UniProt:Q1RPA2:associated_with:MeSH:D010996","document_id":"PMC12756687_window_6","section":null,"start_offset":0,"end_offset":0,"text_span":"Therefore, the presence of both ER and PR plays a crucial role in determining if the primary disease behind the metastatic pleural effusions is breast cancer.","confidence":0.8,"supports":true}
{"relationship_key":"prov:d8c2d365b6944be1a3915de524a40705:diagnosed_by:prov:a6548a1ab3f44a92b903a373205077dc","document_id":"PMC12756687_window_7","section":null,"start_offset":0,"end_offset":0,"text_span":"Effusion cytology turned out to be an accurate tool for the diagnosis of metastatic carcinomas","confidence":0.8,"supports":true}
{"relationship_key":"prov:d8c2d365b6944be1a3915de524a40705:diagnosed_by:prov:a6548a1ab3f44a92b903a373205077dc","document_id":"PMC12756687_window_7","section":null,"start_offset":0,"end_offset":0,"text_span":"Effusion cytology turned out to be an accurate tool for the diagnosis of metastatic carcinomas","confidence":0.8,"supports":true}
{"relationship_key":"MeSH:D001943:diagnosed_by:prov:a6548a1ab3f44a92b903a373205077dc","document_id":"PMC12756687_window_7","section":null,"start_offset":0,"end_offset":0,"text_span":"Effusion cytology turned out to be an accurate tool for the diagnosis of metastatic carcinomas","confidence":0.8,"supports":true}
{"relationship_key":"MeSH:D001943:diagnosed_by:prov:a6548a1ab3f44a92b903a373205077dc","document_id":"PMC12756687_window_7","section":null,"start_offset":0,"end_offset":0,"text_span":"Effusion cytology turned out to be an accurate tool for the diagnosis of metastatic carcinomas","confidence":0.8,"supports":true}
{"relationship_key":"prov:685499061f8c420890b6a36d7399255d:associated_with:MeSH:D010996","document_id":"PMC12756687_window_7","section":null,"start_offset":0,"end_offset":0,"text_span":"due to the evidence that other cancers, including, gynecological malignancies, can metastasize to pleural effusions","confidence":0.7,"supports":true}
{"relationship_key":"prov:685499061f8c420890b6a36d7399255d:associated_with:MeSH:D010996","document_id":"PMC12756687_window_7","section":null,"start_offset":0,"end_offset":0,"text_span":"due to the evidence that other cancers, including, gynecological malignancies, can metastasize to pleural effusions","confidence":0.7,"supports":true}
{"relationship_key":"MeSH:D001943:associated_with:MeSH:D010996","document_id":"PMC12756687_window_7","section":null,"start_offset":0,"end_offset":0,"text_span":"due to the evidence that other cancers, including, gynecological malignancies, can metastasize to pleural effusions","confidence":0.7,"supports":true}
{"relationship_key":"MeSH:D001943:associated_with:MeSH:D010996","document_id":"PMC12756687_window_7","section":null,"start_offset":0,"end_offset":0,"text_span":"due to the evidence that other cancers, including, gynecological malignancies, can metastasize to pleural effusions","confidence":0.7,"supports":true}
